Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

158 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The regulation of glucose effectiveness: how glucose modulates its own production.
Tonelli J, Kishore P, Lee DE, Hawkins M. Tonelli J, et al. Among authors: kishore p. Curr Opin Clin Nutr Metab Care. 2005 Jul;8(4):450-6. doi: 10.1097/01.mco.0000172588.47811.63. Curr Opin Clin Nutr Metab Care. 2005. PMID: 15930973 Review.
Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes.
Hawkins M, Tonelli J, Kishore P, Stein D, Ragucci E, Gitig A, Reddy K. Hawkins M, et al. Among authors: kishore p. Diabetes. 2003 Nov;52(11):2748-58. doi: 10.2337/diabetes.52.11.2748. Diabetes. 2003. PMID: 14578293
Mechanisms of early insulin-sensitizing effects of thiazolidinediones in type 2 diabetes.
Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M. Tonelli J, et al. Among authors: kishore p. Diabetes. 2004 Jun;53(6):1621-9. doi: 10.2337/diabetes.53.6.1621. Diabetes. 2004. PMID: 15161771 Clinical Trial.
Role of hepatic glycogen breakdown in defective counterregulation of hypoglycemia in intensively treated type 1 diabetes.
Kishore P, Gabriely I, Cui MH, Di Vito J, Gajavelli S, Hwang JH, Shamoon H. Kishore P, et al. Diabetes. 2006 Mar;55(3):659-66. doi: 10.2337/diabetes.55.03.06.db05-0849. Diabetes. 2006. PMID: 16505228
Time-dependent effects of free fatty acids on glucose effectiveness in type 2 diabetes.
Kishore P, Tonelli J, Koppaka S, Fratila C, Bose A, Lee DE, Reddy K, Hawkins M. Kishore P, et al. Diabetes. 2006 Jun;55(6):1761-8. doi: 10.2337/db05-0988. Diabetes. 2006. PMID: 16731840 Clinical Trial.
Insulin-sensitizing effects of thiazolidinediones are not linked to adiponectin receptor expression in human fat or muscle.
Li W, Tonelli J, Kishore P, Owen R, Goodman E, Scherer PE, Hawkins M. Li W, et al. Among authors: kishore p. Am J Physiol Endocrinol Metab. 2007 May;292(5):E1301-7. doi: 10.1152/ajpendo.00312.2006. Epub 2007 Jan 9. Am J Physiol Endocrinol Metab. 2007. PMID: 17213476 Clinical Trial.
Increased intrahepatic triglyceride is associated with peripheral insulin resistance: in vivo MR imaging and spectroscopy studies.
Hwang JH, Stein DT, Barzilai N, Cui MH, Tonelli J, Kishore P, Hawkins M. Hwang JH, et al. Among authors: kishore p. Am J Physiol Endocrinol Metab. 2007 Dec;293(6):E1663-9. doi: 10.1152/ajpendo.00590.2006. Epub 2007 Oct 2. Am J Physiol Endocrinol Metab. 2007. PMID: 17911339
Inhibiting gluconeogenesis prevents fatty acid-induced increases in endogenous glucose production.
Kehlenbrink S, Tonelli J, Koppaka S, Chandramouli V, Hawkins M, Kishore P. Kehlenbrink S, et al. Among authors: kishore p. Am J Physiol Endocrinol Metab. 2009 Jul;297(1):E165-73. doi: 10.1152/ajpendo.00001.2009. Epub 2009 May 5. Am J Physiol Endocrinol Metab. 2009. PMID: 19417129 Free PMC article. Clinical Trial.
Adipocyte-derived factors potentiate nutrient-induced production of plasminogen activator inhibitor-1 by macrophages.
Kishore P, Li W, Tonelli J, Lee DE, Koppaka S, Zhang K, Lin Y, Kehlenbrink S, Scherer PE, Hawkins M. Kishore P, et al. Sci Transl Med. 2010 Feb 24;2(20):20ra15. doi: 10.1126/scitranslmed.3000292. Sci Transl Med. 2010. PMID: 20371491
Activation of K(ATP) channels suppresses glucose production in humans.
Kishore P, Boucai L, Zhang K, Li W, Koppaka S, Kehlenbrink S, Schiwek A, Esterson YB, Mehta D, Bursheh S, Su Y, Gutierrez-Juarez R, Muzumdar R, Schwartz GJ, Hawkins M. Kishore P, et al. J Clin Invest. 2011 Dec;121(12):4916-20. doi: 10.1172/JCI58035. Epub 2011 Nov 7. J Clin Invest. 2011. PMID: 22056385 Free PMC article. Clinical Trial.
158 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback